| Drug General Information |
| Drug ID |
DXI1ZV
|
| Drug Name |
SID24275405
|
| Synonyms |
CHEMBL1438722
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Formula |
C19H16N2O3S
|
| Canonical SMILES |
COc1ccc(cc1)C(=O)Nc2nc3c(Cc4cc(OC)ccc34)s2
|
| InChI |
InChI=1S/C19H16N2O3S/c1-23-13-5-3-11(4-6-13)18(22)21-19-20-17-15-8-7-14(24-2)9-12(15)10-16(17)25-19/h3-9H,10H2,1-2H3,(H,20,21,22)
|
| InChIKey |
QVNUNVKGXKPTJR-UHFFFAOYSA-N
|
| Target and Pathway |
| Target(s) |
Estrogen receptor beta |
Target Info |
|
[1]
|
|---|
| Induced myeloid leukemia cell differentiation protein Mcl-1 |
Target Info |
|
[1]
|
|
KEGG Pathway
|
Estrogen signaling pathway
|
|
Prolactin signaling pathwayhsa04151:PI3K-Akt signaling pathway
|
|
MicroRNAs in cancer
|
|
NetPath Pathway
|
TCR Signaling Pathway
|
|
PANTHER Pathway
|
Apoptosis signaling pathway
|
|
CCKR signaling map ST
|
|
Pathway Interaction Database
|
Plasma membrane estrogen receptor signaling
|
|
Validated nuclear estrogen receptor beta network
|
|
Validated nuclear estrogen receptor alpha networke2f_pathway:E2F transcription factor network
|
|
Direct p53 effectors
|
|
IL6-mediated signaling events
|
|
HIF-1-alpha transcription factor network
|
|
Reactome
|
Nuclear Receptor transcription pathway
|
|
WikiPathways
|
SIDS Susceptibility Pathways
|
|
Ovarian Infertility Genes
|
|
Integrated Pancreatic Cancer Pathway
|
|
Nuclear ReceptorsWP254:Apoptosis
|
|
miR-targeted genes in muscle cell - TarBase
|
|
miR-targeted genes in lymphocytes - TarBase
|
|
miR-targeted genes in leukocytes - TarBase
|
|
Apoptosis Modulation and Signaling
|
| References |
| REF 1 | URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017 |
|---|
